Diffusion Pharmaceuticals Receives FDA Guidance for International Phase 1b/2b COVID-19 Clinical Program with TSC Nasdaq:DFFN
Guidance being incorporated into global study protocolEnrollment of first patient now expected in August CHARLOTTESVILLE, Va., July 27, 2020 (GLOBE...











